Ten common questions (and their answers) about off-label drug use.
about
Off-label use of sodium valproate for schizophreniaDispensing medical countermeasures: emergency use authorities and liability protectionsEarly clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.Pimping up Drugs Recovered, Superannuated and Under Exploited Drugs - An Introduction to the Basics of Drug Reprofiling.Off-Label Prescribing by Psychiatrists: What is the Practitioner's Liability?Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.Use of contrast media in diagnostic imaging: medico-legal considerationsTrends in Off-Label Use of Second-Generation Antipsychotics in the Medicare Population From 2006 to 2012.Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.The high cost of cancer drugs and what we can do about it.Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in YouthPrescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.Choosing Wisely: Wise Choices in Psychiatry.Off-label use of tumour necrosis factor-alpha inhibitors and anakinra at an Australian tertiary hospital.When should we use contrast material in cardiac MRI?Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.Physician-pharmacist agreement about off-label use of medications in private clinical settings in Baghdad, Iraq.Integrating value assessment into discussions about the price of cancer drugs.Off-label, but on-target: use of regadenoson with exercise.Combining information from a clinical data warehouse and a pharmaceutical database to generate a framework to detect comorbidities in electronic health records.Off-label use of drugs in regional anesthesia: A need for setting up policies.Off-label prescriptions in intensive care unit: the Chinese experience.Removing barriers to early CT scanning in emergency and inpatient radiology.An evidence-based systematic review of the off-label uses of lisinoprilThe Applicability of N: Ancient Debates and Modern Experimental Design
P2860
Q28541404-2ED25E59-C3F8-4692-948E-47F61D0886D5Q30204355-E44BB844-BE0B-43F8-B5F4-B8B9C037F582Q30800602-1C1A68AB-05F3-4216-9F36-C406E3C88ECCQ33600352-6B115AFD-55F7-4CE3-9309-BF95C949AC7CQ34672146-2F52301B-7F18-4137-B23A-FA669760E9F3Q34680866-EC314DBB-ACE0-455C-A47D-F5C0CD619587Q35983399-B7851DFB-A7AA-4E6D-B948-61E312516CDFQ35990340-FD270C1A-F2C0-462D-8532-ABFBEC89B9FFQ36410220-4D82E6A5-5968-4E0B-841B-7CB9E4802EBBQ36512856-0BA298B5-FC07-4713-9B08-348EC12CC79FQ37102113-30D35CF7-249C-41E7-B005-F626B181BEE2Q37309608-B271E5C4-4648-45EF-BF4A-B9490517A30BQ37343665-A8C5A7FF-752E-480D-BDF2-112E7781CE4AQ38826765-7882A0DD-8957-4D63-859D-374F8936FCAEQ39290073-708E50F8-7DCF-404F-B093-F080C444E066Q39821386-19411435-29A9-4973-9B81-D48792BDF033Q40117839-B5EF7B2C-E14F-481D-A96F-45DF09A4CD43Q41702190-4B9E01FA-63DE-4082-ACFE-D223D5785C8BQ42337498-33E6DC50-DB20-4128-AB8B-A31EC3E6E549Q45323311-5BA1BF34-27B0-4AF8-9BB8-623AC0A6C169Q47556639-AAF6F3EA-E1CA-4162-B9B5-563037B51B4CQ49252878-A497E9FD-C226-4E2F-917C-A7479441F5DFQ49741733-9C8608E8-A5CD-447B-AF9E-C019CACF7978Q50199991-E2A76B17-AA92-4D7F-852D-97F3276512EDQ57487671-95DFB951-2E40-4D66-AC6E-2FE39E64F47EQ58715986-533668E8-CA4A-4E4E-8C63-FD62650B5282
P2860
Ten common questions (and their answers) about off-label drug use.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ten common questions (and their answers) about off-label drug use.
@ast
Ten common questions (and their answers) about off-label drug use.
@en
type
label
Ten common questions (and their answers) about off-label drug use.
@ast
Ten common questions (and their answers) about off-label drug use.
@en
prefLabel
Ten common questions (and their answers) about off-label drug use.
@ast
Ten common questions (and their answers) about off-label drug use.
@en
P2860
P1476
Ten common questions (and their answers) about off-label drug use.
@en
P2093
Christopher M Wittich
William L Lanier
P2860
P304
P356
10.1016/J.MAYOCP.2012.04.017
P407
P577
2012-08-06T00:00:00Z